Arrowhead Pharmaceuticals Inc (ARWR)
Operating profit margin
| Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating income (ttm) | US$ in thousands | -601,080 | -547,207 | -473,769 | -299,413 | -205,002 | -180,502 | -150,708 | -157,320 | -178,507 | -159,560 | -118,519 | -188,304 | -149,037 | -134,273 | -118,351 | -112,359 | -93,158 | -33,401 | 1,141 | 45,392 |
| Revenue (ttm) | US$ in thousands | 3,551 | 14,386 | 25,053 | 166,263 | 225,258 | 245,998 | 267,743 | 278,338 | 243,231 | 249,939 | 263,418 | 144,424 | 138,288 | 107,638 | 89,123 | 79,841 | 87,993 | 123,653 | 138,974 | 163,593 |
| Operating profit margin | -16,927.06% | -3,803.75% | -1,891.07% | -180.08% | -91.01% | -73.38% | -56.29% | -56.52% | -73.39% | -63.84% | -44.99% | -130.38% | -107.77% | -124.74% | -132.80% | -140.73% | -105.87% | -27.01% | 0.82% | 27.75% |
September 30, 2024 calculation
Operating profit margin = Operating income (ttm) ÷ Revenue (ttm)
= $-601,080K ÷ $3,551K
= -16,927.06%
Arrowhead Pharmaceuticals Inc's operating profit margin has shown significant fluctuations over the past few quarters. The company experienced negative operating profit margins ranging from -16,927.06% to -1,891.07% in the recent quarters, indicating substantial losses compared to revenue. However, there was a slight improvement in the most recent quarter, with the operating profit margin reaching -180.08%.
The trend over the last few quarters shows a gradual decrease in the negative operating profit margin, suggesting potential improvements in the company's operational efficiency. Despite the ongoing losses, the company may be taking steps to mitigate its losses and enhance profitability.
It is important for Arrowhead Pharmaceuticals Inc to continue monitoring and analyzing its operating profit margin to ensure sustainability and long-term profitability. Measures to control costs, optimize revenue streams, and enhance operational effectiveness could be crucial for the company's financial health and future success.
Peer comparison
Sep 30, 2024